| Income Statement |
| Total Revenue | 1.30B |
|
| Revenues (USD) | 1.30B |
| Cost of Revenue | 469.80M |
| Gross Profit | 828.20M |
| Operating Expenses | 412.90M |
| Research and Development Expense | 211.40M |
| Selling, General and Administrative Expense | 179.50M |
| Operating Income | 415.30M |
| Interest Expense | 37.40M |
| Income Tax Expense | 76.90M |
| Net Income | 240.10M |
| Net Income Common Stock | 240.10M |
| Net Income Common Stock (USD) | 240.10M |
| Consolidated Income | 240.10M |
| Earnings per Basic Share | 1.84 |
| Earnings per Basic Share (USD) | 1.84 |
| Earnings per Diluted Share | 1.83 |
| Earning Before Interest & Taxes (EBIT) | 354.40M |
| Earning Before Interest & Taxes (USD) | 354.40M |
| Weighted Average Shares | 130.76M |
| Weighted Average Shares Diluted | 130.99M |
| Balance Sheet |
| Cash and Equivalents | 1.16B |
| Cash and Equivalents (USD) | 1.16B |
| Trade and Non-Trade Receivables | 92.90M |
| Current Assets | 1.97B |
| Property, Plant & Equipment Net | 191.20M |
| Total Assets | 8.00B |
| Debt Current | 15.00M |
| Total Debt | 3.84B |
| Current Liabilities | 3.12B |
| Debt Non-Current | 3.83B |
| Total Liabilities | 7.99B |
| Accumulated Retained Earnings (Deficit) | -3.17B |
| Accumulated Other Comprehensive Income | 40.30M |
| Shareholders Equity | 6.70M |
| Shareholders Equity (USD) | 6.70M |
| Assets Non-Current | 6.02B |
| Total Debt (USD) | 3.84B |
| Deferred Revenue | 3.51B |
| Goodwill and Intangible Assets | 4.57B |
| Liabilities Non-Current | 4.87B |
| Trade and Non-Trade Payables | 122.90M |
| Tax Assets | 912.60M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 13.30M |
| Net Cash Flow from Financing | -543.30M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -106.20M |
| Capital Expenditure | -5.10M |
| Issuance (Purchase) of Equity Shares | -543.90M |
| Net Cash Flow from Investing | -5.10M |
| Net Cash Flow from Operations | 442.50M |
| Effect of Exchange Rate Changes on Cash | -300.00K |
| Share Based Compensation | 70.20M |